Riskpilot← Back to searchSign inGet full accessLUNGEHELSE AS
ASActiveOrg 993495182Damveien 40, 3121 NøtterøyGeneral medical practice activities · NACE 8621Est. 20090 employees
Revenue 2024
NOK 1,8M
+827% vs 2023
EBITDA margin
90.7%
+635% vs 2023
Equity ratio
81.1%
Financial strength
Net profit 2024
NOK 1,8M
+1180% vs 2023
| Revenue | NOK 1,8M | +827% |
| EBITDA | NOK 1,6M | +635% |
| Net profit | NOK 1,8M | +1180% |
| Total assets | NOK 8,4M | +31% |
| Equity | NOK 6,8M | +10% |
| Employees | 0 | — |
Legal name
LUNGEHELSE AS
Org number
993495182
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
14. januar 2009
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Legevirksomhet, medisinske konsulenttjenester samt medisinsk forskning og utvikling og dermed forbundne oppgaver, kjøp, salg og drift av fast eiendom samt deltagelse i andre selskaper og alt hva hermed er forbundet.
Address
Damveien 40, 3121 Nøtterøy
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 532 | 6 103 | 5 046 | 192 | 1 782 |
| Staff expenses | −2 067 | −2 077 | −987 | −227 | −11 |
| EBITDA | 1 570 | 1 831 | 2 589 | −302 | 1 616 |
| Depreciation & amort. | −403 | −361 | −146 | −0 | −0 |
| EBIT | 1 167 | 1 470 | 2 443 | −302 | 1 616 |
| Net financials | −92 | −66 | −0 | 87 | 579 |
| Profit before tax | 1 075 | 1 404 | 2 443 | −215 | 2 194 |
| Tax | 246 | 276 | 517 | −47 | 379 |
| Net profit | 829 | 1 128 | 1 926 | −168 | 1 816 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 12 889 | 12 147 | 7 129 | 6 421 | 8 384 |
| Equity | 8 774 | 4 502 | 6 328 | 6 160 | 6 799 |
| Long-term debt | 1 848 | 25 | 265 | 218 | 182 |
| Short-term debt | 2 268 | 7 620 | 536 | 43 | 1 403 |
| Total debt | 4 116 | 7 645 | 801 | 261 | 1 585 |
EBITDA margin
90.7%
This company
15.8%
Market median
+474% vs market
20202024
Equity ratio
81.1%
This company
38.2%
Market median
+112% vs market
20202024
Return on equity
26.7%
This company
18.4%
Market median
+45% vs market
20202024
Net profit margin
101.9%
This company
8.1%
Market median
+1158% vs market
20202024
Asset turnover
0.21×
This company
1.12×
Market median
-81% vs market
20202024
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TN Deputy Member | Deputy Member | 2009 |
TA Chief Executive Officer | Chief Executive Officer | 2009 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LUNGEHELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Turid Nakling Kristiansen | Deputy Member | 0 companies |
| Terje Aage Kristiansen | Chief Executive Officer | 0 companies |